349 related articles for article (PubMed ID: 23740407)
21. Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells.
Xu XY; Guo C; Yan YX; Guo Y; Li RX; Song M; Zhang XZ
Mol Med Rep; 2012 Aug; 6(2):409-15. PubMed ID: 22580758
[TBL] [Abstract][Full Text] [Related]
22. Effect of cytosolic phospholipase A2 on proinflammatory cytokine-induced bone resorptive genes including receptor activator of nuclear factor kappa B ligand in human dental pulp cells.
Kim YS; Min KS; Lee HD; Oh HW; Kim EC
J Endod; 2010 Apr; 36(4):636-41. PubMed ID: 20307736
[TBL] [Abstract][Full Text] [Related]
23. The liver X receptor promotes macrophage differentiation and suppresses osteoclast formation in mouse RAW264.7 promyelocytic leukemia cells exposed to bacterial lipopolysaccharide.
Robertson Remen KM; Gustafsson JÅ; Andersson G
Biochem Biophys Res Commun; 2013 Jan; 430(1):375-80. PubMed ID: 23159616
[TBL] [Abstract][Full Text] [Related]
24. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
[TBL] [Abstract][Full Text] [Related]
25. Dual modulation of osteoclast differentiation by lipopolysaccharide.
Zou W; Bar-Shavit Z
J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
[TBL] [Abstract][Full Text] [Related]
26. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.
Ikeda F; Matsubara T; Tsurukai T; Hata K; Nishimura R; Yoneda T
J Bone Miner Res; 2008 Jun; 23(6):907-14. PubMed ID: 18251700
[TBL] [Abstract][Full Text] [Related]
27. A novel small molecule, NecroX-7, inhibits osteoclast differentiation by suppressing NF-κB activity and c-Fos expression.
Kim HJ; Yoon KA; Lee MK; Kim SH; Lee IK; Kim SY
Life Sci; 2012 Nov; 91(19-20):928-34. PubMed ID: 23000100
[TBL] [Abstract][Full Text] [Related]
28. Monosodium Urate in the Presence of RANKL Promotes Osteoclast Formation through Activation of c-Jun N-Terminal Kinase.
Choe JY; Park KY; Kim SK
Mediators Inflamm; 2015; 2015():597512. PubMed ID: 26347587
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB.
Kim WS; Kim HJ; Lee ZH; Lee Y; Kim HH
Exp Cell Res; 2013 Feb; 319(4):436-46. PubMed ID: 23246654
[TBL] [Abstract][Full Text] [Related]
30. Ormeloxifene inhibits osteoclast differentiation in parallel to downregulating RANKL-induced ROS generation and suppressing the activation of ERK and JNK in murine RAW264.7 cells.
Kharkwal G; Chandra V; Fatima I; Dwivedi A
J Mol Endocrinol; 2012 Jun; 48(3):261-70. PubMed ID: 22493142
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of RANKL-independent cell fusion of osteoclast-like cells induced by TNF-alpha, lipopolysaccharide, or peptidoglycan.
Hotokezaka H; Sakai E; Ohara N; Hotokezaka Y; Gonzales C; Matsuo K; Fujimura Y; Yoshida N; Nakayama K
J Cell Biochem; 2007 May; 101(1):122-34. PubMed ID: 17171644
[TBL] [Abstract][Full Text] [Related]
32. DICAM inhibits osteoclast differentiation through attenuation of the integrin αVβ3 pathway.
Jung YK; Han SW; Kim GW; Jeong JH; Kim HJ; Choi JY
J Bone Miner Res; 2012 Sep; 27(9):2024-34. PubMed ID: 22492581
[TBL] [Abstract][Full Text] [Related]
33. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.
Hsieh TP; Sheu SY; Sun JS; Chen MH
Phytomedicine; 2011 Jan; 18(2-3):176-85. PubMed ID: 20554188
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of eugenol on RANKL-induced osteoclast formation via attenuation of NF-κB and MAPK pathways.
Deepak V; Kasonga A; Kruger MC; Coetzee M
Connect Tissue Res; 2015 Jun; 56(3):195-203. PubMed ID: 25405641
[TBL] [Abstract][Full Text] [Related]
35. Sinomenine down-regulates TLR4/TRAF6 expression and attenuates lipopolysaccharide-induced osteoclastogenesis and osteolysis.
He L; Duan H; Li X; Wang S; Zhang Y; Lei L; Xu J; Liu S; Li X
Eur J Pharmacol; 2016 May; 779():66-79. PubMed ID: 26965104
[TBL] [Abstract][Full Text] [Related]
36. Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells.
Ko SY
Arch Oral Biol; 2012 Dec; 57(12):1623-32. PubMed ID: 22795564
[TBL] [Abstract][Full Text] [Related]
37. Cell adhesion signaling regulates RANK expression in osteoclast precursors.
Mochizuki A; Takami M; Miyamoto Y; Nakamaki T; Tomoyasu S; Kadono Y; Tanaka S; Inoue T; Kamijo R
PLoS One; 2012; 7(11):e48795. PubMed ID: 23139818
[TBL] [Abstract][Full Text] [Related]
38. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
[TBL] [Abstract][Full Text] [Related]
39. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation.
Sundaram K; Nishimura R; Senn J; Youssef RF; London SD; Reddy SV
Exp Cell Res; 2007 Jan; 313(1):168-78. PubMed ID: 17084841
[TBL] [Abstract][Full Text] [Related]
40. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]